A survey of the best-known active scientific controversies in nutrition — saturated fat and cardiovascular disease, dietary cholesterol, low-carb vs low-fat, ultra-processed foods, red meat and cancer, salt and blood pressure, and the replication status of popular single-nutrient claims. Use when a question asks whether a widely reported nutritional claim is settled, or when the department needs to distinguish "contested but plausible" from "settled" from "disproven."
Standardmäßig ist der Prompt ausgewählt, der zuerst die Quelle prüft. Sie können zu einem direkten Befehl wechseln oder eine lokale Kopie herunterladen.
Quelldateien prüfen
Lesen Sie SKILL.md und alle von SkillsMP angezeigten Begleitdateien, bevor Sie sich für eine Installation entscheiden.
Mit Codex oder Claude installieren Kopieren Sie diesen Prompt, fügen Sie ihn in Codex, Claude oder einen anderen Assistant ein und lassen Sie die Skill-Seite prüfen und installieren.
Ein direkter Befehl überspringt den Prüf-Prompt. Prüfen Sie die Quelle, bevor Sie ihn ausführen.
A survey of the best-known active scientific controversies in nutrition — saturated fat and cardiovascular disease, dietary cholesterol, low-carb vs low-fat, ultra-processed foods, red meat and cancer, salt and blood pressure, and the replication status of popular single-nutrient claims. Use when a question asks whether a widely reported nutritional claim is settled, or when the department needs to distinguish "contested but plausible" from "settled" from "disproven."
Nutrition is a discipline in which several first-order questions remain genuinely contested after decades of research, and in which many second-order claims that were popular in earlier decades did not survive replication. This is neither a scandal nor an indictment of the field — it is the natural state of a science where the gold-standard methodology (controlled long-duration feeding) is largely impossible and the workhorse methodology (observational cohorts with self-report) has known large biases. A department that pretends otherwise teaches poorly. This skill catalogs the major active controversies, documents the replication status of several popular claims, and gives heuristics for how the department should talk about uncertainty.
Agent affinity: ancel-keys (cardiovascular and lipid questions), marion-nestle (policy and industry-influence dimensions), adelle-davis (historical-transparency examples of claims that did not replicate)
Before the catalog, the shared vocabulary. The department uses five strength-of-evidence tiers:
Settled. Supported by converging evidence from multiple independent study designs including controlled trials. Example: citrus cures scurvy. Example: folic acid fortification reduces neural tube defects.
Strong. Supported by multiple lines of evidence with some methodological limitations. Example: dietary saturated fat raises LDL-C in controlled feeding.
Contested but plausible. Supported by some lines of evidence, challenged by others, with active ongoing debate. Example: whether dietary saturated fat raises cardiovascular event rates in free-living populations over decades.
Weak. Supported mainly by mechanistic or observational evidence that has not been confirmed in controlled settings. Example: most claims about specific polyphenols and chronic disease.
Disproven or not replicated. Previously believed; challenged or overturned by subsequent evidence. Example: the claim that dietary cholesterol in isolation raises serum cholesterol meaningfully in most people. Example: several of Adelle Davis's specific dose-response claims for vitamins.
Explicit tier labels reduce the chance that readers mistake an uncertain claim for a settled one or dismiss a settled one as merely contested.
Active controversy 1 — Saturated fat and cardiovascular disease
The claim. Dietary saturated fat intake raises cardiovascular disease risk.
History. Ancel Keys's Seven Countries Study (launched 1958) reported a correlation between saturated fat intake and coronary heart disease mortality across populations. Subsequent controlled-feeding studies (MRC Oslo, LA Veterans, Finnish Mental Hospital, Minnesota Coronary Experiment) produced mixed results for clinical outcomes; most found that substituting polyunsaturated fat for saturated fat lowered serum cholesterol, but outcome effects were inconsistent. The AHA and the US Dietary Guidelines have recommended limiting saturated fat since the 1970s.
Where it stands. The mechanism — saturated fat suppresses LDL receptor expression, raising LDL-C — is strong. The clinical-outcome question is contested but plausible. Re-analyses of the Minnesota Coronary Experiment (Ramsden et al., 2016) found no mortality benefit from the intervention despite the expected cholesterol reduction, which strengthened the critic case. Subsequent meta-analyses by the Cochrane group and others have found small but statistically defensible benefits from reducing saturated fat, especially when it is replaced by polyunsaturated fat rather than refined carbohydrate.
What the department says. The mechanism is well-supported. The magnitude of clinical benefit from reducing saturated fat is real but modest and depends on the comparator. Replacing saturated fat with polyunsaturated fat appears to provide benefit; replacing it with refined carbohydrate does not. Replacing it with whole-food carbohydrate is somewhere in between.
Active controversy 2 — Dietary cholesterol and serum cholesterol
The claim. Dietary cholesterol (eggs, shellfish) raises serum cholesterol.
Where it stands. This was a dietary-guideline target from the 1980s through 2015. The 2015 DGAC concluded that dietary cholesterol in isolation has a small effect on serum cholesterol in most people, and the explicit 300 mg/day limit was dropped. Disproven or at least substantially attenuated as a first-order claim for most people. A minority (so-called "hyperresponders") do show meaningful serum cholesterol changes with dietary cholesterol, so the claim is not zero.
What the department says. For most people, dietary cholesterol is a weak dietary lever. Individual variation is substantial. Saturated fat is a larger dietary lever than cholesterol per se for most people.
Active controversy 3 — Low-carb vs low-fat for weight loss
The claim. Low-carbohydrate diets are more effective than low-fat diets for weight loss.
Where it stands. Controlled-feeding studies of carefully matched protein and calorie diets generally find no meaningful advantage for low-carb over low-fat for short-term fat loss. Free-living trials (where people choose their own food within a broad dietary pattern) sometimes find low-carb advantages, usually attributable to spontaneous calorie reduction when refined carbohydrates are removed. The DIETFITS study (Gardner et al., 2018) found essentially no difference between low-fat and low-carb groups at 12 months when both were instructed to eat high-quality food.
What the department says.Contested but with a clear pattern. At the metabolic ward level, the diets are roughly equivalent for weight loss when calories and protein are matched. At the real-world level, either can work and adherence is the limiting factor. The extraordinary claims about carbohydrate-insulin being the master regulator of body fat have not survived metabolic-ward testing in the strong form.
Active controversy 4 — Ultra-processed foods
The claim. Ultra-processed foods (UPFs), independent of their macronutrient composition, cause excess energy intake and weight gain.
Where it stands. Hall et al. (2019, NIH) conducted a rare inpatient crossover study comparing matched ultra-processed and unprocessed diets; participants ate ~500 kcal/day more on the ultra-processed diet and gained weight. This is a strong mechanistic result from a small but well-controlled study. The broader observational literature on UPF and chronic disease is consistent but vulnerable to confounding. The NOVA classification system used to define UPF is itself contested — it lumps products of very different compositions together.
What the department says. The Hall et al. study is evidence that highly processed food environments drive overconsumption even when nutrients are matched. The policy implication — regulate UPF as a category — requires a sharper definition than NOVA provides. The science is active.
Active controversy 5 — Red meat and cancer
The claim. Red and processed meat consumption increases colorectal cancer risk.
Where it stands. IARC classified processed meat as Group 1 (carcinogenic) and red meat as Group 2A (probably carcinogenic) in 2015. The effect sizes are small — hazard ratios typically in the 1.1–1.3 range in cohort studies — and FFQ-based cohort studies are the primary evidence. A 2019 guideline from NutriRECS (Johnston et al.) reviewed the same evidence and concluded the certainty was too low to recommend reduction, sparking a major methodological dispute. Contested but plausible. The direction is consistent across studies; the magnitude is small and the methodology is not strong enough to settle the question.
What the department says. There is a small but consistent association. Processed meat evidence is stronger than fresh red meat evidence. Individual dietary decisions should weigh this against other factors; the effect is not large enough to support dramatic claims in either direction.
Active controversy 6 — Salt and blood pressure, salt and cardiovascular disease
The claim. Reducing dietary sodium lowers blood pressure and cardiovascular events.
Where it stands. The blood pressure effect is strong — controlled-feeding studies consistently find that sodium reduction lowers blood pressure, with the effect larger in salt-sensitive individuals and in people with hypertension. The cardiovascular-event effect is contested. The PURE study (Mente et al., 2018) found a J-shaped relationship — both very low and very high sodium intake were associated with worse outcomes — while other cohorts found monotonic benefit to lower sodium. The target range remains disputed.
What the department says. Reducing very high sodium intake to a moderate level is well-supported. Reducing moderate sodium intake to very low levels is not well-supported and may be harmful. Individuals with salt-sensitive hypertension benefit from sodium reduction.
Replication status of popular single-nutrient claims
A representative sample of historical claims and their current status:
Claim
Originator era
Current tier
Vitamin C cures the common cold (Pauling, megadose)
1970s
Not replicated
Vitamin E supplementation prevents heart disease
1990s
Not replicated (several trials null or harmful)
Beta-carotene supplementation prevents lung cancer
This table is not exhaustive and is updated as trials report. The pattern is instructive: single-nutrient supplementation claims fail more often than whole-dietary-pattern claims, and fortification at population level succeeds when the deficiency is established and the dose is well-targeted.
Adelle Davis and the historical-transparency reference
Several specific high-dose vitamin and mineral claims popularized by Adelle Davis in Let's Eat Right to Keep Fit and related books did not survive replication. In at least one documented case, a child suffered hypernatremia and died after her parent followed a salt-administration protocol described in Davis's writing; the case became legal and is part of the historical record. The department uses Davis as a reference point for how to present popular-nutrition writing transparently: the enthusiasm and the food-quality advocacy are real contributions; several specific claims and dose recommendations were wrong and in at least one case harmful. See the agent AGENT.md for adelle-davis for a more complete treatment.
Worked example — reading "vitamin X prevents disease Y"
A student reports a news article claiming that a named supplement prevents a named disease. The department applies:
Is this a single-nutrient claim or a dietary-pattern claim? Single-nutrient claims have a worse replication record.
Is the evidence observational or interventional? Observational evidence alone rarely settles a supplementation question.
What is the plausible mechanism? If mechanism is absent or relies on in vitro effects at unachievable doses, skepticism is warranted.
Have high-quality trials been run? Check for RCTs with clinical endpoints.
Is there a dose-response? Does more work better, or is there a plateau? Is there a range above which harm appears?
Report with a tier label. "Weak" or "not replicated" is an honest answer that a good student can use; "strong" is reserved.
Assessment protocol for a contested claim
Identify the exact claim. Claims shift subtly in retelling. Find the original paper or statement.
Find the major opposing evidence. Real controversies have two or more credible camps. If only one side exists, the claim is probably not contested — it may be settled, or it may be fringe.
Identify the methodological basis of each camp. Are the disputing studies using different instruments? Different populations? Different outcomes?
Check whether independent replications have been attempted. Failure to replicate is the strongest signal against a claim.
Name the tier. Report a strength-of-evidence label explicitly.
Name what would change your mind. A good answer to a contested question includes the condition under which the answer would flip.
Routing heuristics
Cardiovascular / lipid controversies → ancel-keys
Food policy, guideline-versus-evidence gaps, industry funding questions → marion-nestle
